Clinical Research Study for Individuals with Parkinson's Disease

Protocol Title Clinical Research Study for Individuals with Parkinson's Disease
Summary This Phase III study is testing an investigational form of a currently marketed oral medication for Parkinson's disease.

Currently approved extended-release, oral carbidopa-levodo products are absorbed over 4-6 hours. However, the absorption appears to be delayed and may require supplemental doses of immediate release carbidopa-levodo. Therefore, there is a need to develop an improved oral extended release product that can consistently deliver fast and stable levodopa plasma concentrations.

IPX066, the medication being tested in this study, is an oral investigational extended-release product intended to produce rapid and sustained plasma concentrations of levodopa over 6 hours following a single oral dose.

If you are eligible to participate in this 22-week trial, you will need to visit the research study site for an initial assessment visit and up to 8 more times on week's 1, 3, 5, 7, 9, 12, 17, and 22 of the study. You will receive all study-related medical care, medication, and laboratory work at no financial cost to you for the duration of your participation in the study and you may-be provided transportation costs for attending the study visits.
Therapeutic Area Parkinson's
Age Range Minimum Age : 30
Purpose This clinical study is designed to evaluate the safety and efficacy of the investigational drug IPX066 for individuals with Advanced Parkinson's Disease.
Who is Eligible? To participate you must:
  • Have a confirmed diagnosis of Parkinson’s Disease
  • Be at least 30 years old at the time of your Parkinson’s Disease diagnosis
  • Currently be taking the medication carbidopa-levodopa (e.g. SINEMET®)

If you are interested in taking a brief questionnaire to determine if you are eligible to participate in this important clinical trial, please Register Now as a patient.

Once you complete the registration process, return to this page and you will see the link to the questionnaire right above the trial site locations. Thank you for your interest in this clinical trial.

If your have already registered, please log in at the top right of the website

*First Name
*Last Name
Age
*Email
*Address 1
Address 2
*City
*State
*Zip
*User Name
*Password
*Confirm Password
*Trial Interests Allergies/Asthma
Alzheimer's Disease
Arthritis
Cancer
Cancer - Breast
Cancer - Head and Neck
Cancer - Lung
Cancer - Pancreatic
Cancer - Prostate
COPD/Emphysema
Crohn's Disease
Cystic Fibrosis
Depression
Diabetes
Epilepsy
Fibromyalgia
Heart Disease
Low Back Pain
Lupus
Men's Health
Menopause
Multiple Sclerosis
Other
Parkinson's
Pediatric Health
Peripheral Arterial Disease (PAD)
Vascular Disease
Trial Notification Opt In yes = Please email me updates on my preferred clinical trials

Trial Locations per State
LocationStateAddress

Trial Materials and Media

Images

Click on the Poster to learn more
Call us toll-free at 877-997-8839 if you prefer to speak with a live operator

Printed Material

Do You Qualify for This Clinical Trial? Hit the 'Patients
Click to enlarge
For a full list of trial sites visit www.clinicaltrials.gov and enter identifier NCT00974974
Click to enlarge

Your Name:
Your Email:
Friend's Name:
Friend's Email: